| Product Code: ETC9968208 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Injectable Targeted Therapy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Injectable Targeted Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Injectable Targeted Therapy Market - Industry Life Cycle |
3.4 United States (US) Injectable Targeted Therapy Market - Porter's Five Forces |
3.5 United States (US) Injectable Targeted Therapy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Injectable Targeted Therapy Market Revenues & Volume Share, By Therapy Area, 2021 & 2031F |
3.7 United States (US) Injectable Targeted Therapy Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 United States (US) Injectable Targeted Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Injectable Targeted Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring targeted therapies |
4.2.2 Growing demand for personalized medicine and precision treatments |
4.2.3 Advancements in biotechnology leading to the development of innovative injectable targeted therapies |
4.3 Market Restraints |
4.3.1 High cost associated with targeted therapies |
4.3.2 Stringent regulatory requirements for approval and commercialization of injectable targeted therapies |
4.3.3 Limited reimbursement coverage for certain targeted therapies |
5 United States (US) Injectable Targeted Therapy Market Trends |
6 United States (US) Injectable Targeted Therapy Market, By Types |
6.1 United States (US) Injectable Targeted Therapy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.1.4 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Small-Molecules, 2021- 2031F |
6.1.5 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Immunotoxins, 2021- 2031F |
6.1.6 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Injectable Targeted Therapy Market, By Therapy Area |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Cardiometabolism, 2021- 2031F |
6.2.4 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Immunology, 2021- 2031F |
6.2.5 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.6 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Neuroscience, 2021- 2031F |
6.2.7 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Ophthalmology, 2021- 2031F |
6.3 United States (US) Injectable Targeted Therapy Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Injectable Targeted Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 United States (US) Injectable Targeted Therapy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Injectable Targeted Therapy Market Import-Export Trade Statistics |
7.1 United States (US) Injectable Targeted Therapy Market Export to Major Countries |
7.2 United States (US) Injectable Targeted Therapy Market Imports from Major Countries |
8 United States (US) Injectable Targeted Therapy Market Key Performance Indicators |
8.1 Number of FDA approvals for new injectable targeted therapies |
8.2 Patient adherence and compliance rates with injectable targeted therapies |
8.3 Rate of adoption of injectable targeted therapies by healthcare providers and institutions |
9 United States (US) Injectable Targeted Therapy Market - Opportunity Assessment |
9.1 United States (US) Injectable Targeted Therapy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Injectable Targeted Therapy Market Opportunity Assessment, By Therapy Area, 2021 & 2031F |
9.3 United States (US) Injectable Targeted Therapy Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 United States (US) Injectable Targeted Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Injectable Targeted Therapy Market - Competitive Landscape |
10.1 United States (US) Injectable Targeted Therapy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Injectable Targeted Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here